Together, we hypothesize that RILP interacts with RalGDS, and consequently inhibits its GEF activity, resulting in inhibition of RalA activation, thus suppresses the secretion and cytoskeleton reconstruction required for cell migration and invasion of cancer cells. The gene discussed is RALA; the disease is cancer.